This public notice announces that Mankind Pharma Limited intends to discontinue marketing specific products, including Electrokind Sachet and Mupiways Ointment, within six months.The affected products, which also include Clonabris tablets and ODPEP-IV injection, may no longer be available in the market after this period.Patients currently using these medicines are advised to consult their doctor to discuss prescribing alternative treatments.